L, M.A. et al. 2019. THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB. Journal of the ASEAN Federation of Endocrine Societies. 34, (Jul. 2019), 17.